Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8944927 | Clinical Microbiology and Infection | 2018 | 33 Pages |
Abstract
The rate of HBsAg loss was relatively high and the rate of hepatic events was low in noncirrhotic patients who discontinued nucleoside analogue therapy.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
C.-H. Chen, C.-H. Hung, J.-H. Wang, S.-N. Lu, T.-H. Hu, C.-M. Lee,